White Pine Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$455K Buy
3,056
+2
+0.1% +$281 0.11% 183
2026
Q2
$386K Sell
3,054
-10
-0.3% -$1.32K 0.09% 195
2026
Q1
$427K Hold
3,064
– – 0.12% 179
2025
Q4
$376K Buy
3,064
+81
+3% +$9.8K 0.1% 180
2025
Q3
$331K Buy
2,983
+43
+1% +$4.89K 0.09% 192
2025
Q2
$326K Buy
2,940
+535
+22% +$56.9K 0.1% 187
2025
Q1
$269K Sell
2,405
-25
-1% -$2.58K 0.09% 200
2024
Q4
$224K Buy
+2,430
New +$219K 0.08% 208

Other funds holding GILD

White Pine Capital's GILD Position: Q3 2026 in Review

White Pine Capital increased its Gilead Sciences (GILD) stake by 0.07% in Q3 2026, buying an estimated $281 and bringing the position to 3,056 shares worth $455K. The position accounts for 0.11% of the portfolio, ranked #183.

White Pine Capital first reported a position in GILD in Q4 2024 and has held it in 8 quarters since. 2,355 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • White Pine Capital held 3,056 shares of Gilead Sciences worth $455K as of Q3 2026.
  • White Pine Capital bought 2 Gilead Sciences shares in Q3 2026, an estimated $281.
  • Gilead Sciences made up 0.11% of White Pine Capital's portfolio in Q3 2026, its #183 holding.
  • White Pine Capital first reported a position in Gilead Sciences in Q4 2024 and has held it in 8 quarters since.
  • 2,355 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on White Pine Capital's 13F filing for Q3 2026, filed 9 Nov 2026.